Clinical Trial Update: a Single Arm, Phase II Multicenter Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of Iparomlimab and Tuvonralima b and Chemotherapy ± Bevacizumab Induction Therapy Followed by Concurrent Chemoradiotherapy in Patients With Advanced Cervical Cancer . [Phase 2]

View source ↗

Summary

Phase II, single-arm multicenter trial evaluating the safety and efficacy of combining Iparomlimab and Tuvonralima b with chemotherapy (± Bevacizumab) induction…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Tuvonralima b (tuvonralima b)
• iparomlimab

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Cervical Cancer Stage IVA, Cervical Cancer Metastatic | Phase 2 | Status: NOT_YET_RECRUITING